Digital Event
June 13th | 9:30AM CSTSponsored by Cytiva Mike Webb, Ph.D.Founder and CEO at Mike Webb PharmaSpeaker
Profile
Mike Webb PhD was the VP of Development Chemistry and Analysis for GSK in the UK and was heavily involved in developing GSK’s oligonucleotide pipeline. Since leaving GSK in 2016 he has been consulting with Big Pharma and Biotechnology companies in the development, analysis and manufacture of therapeutic oligonucleotides from pre-clinical to marketing submission.
Agenda Sessions
Addressing the Challenges in Developing a Control Strategy for Therapeutic Oligonucleotides
, 09:00View Session